Alzheimer's Research & Therapy invites submissions for a thematic series focusing on the use of artificial intelligence, machine learning and related techniques in dementia research.
Find out more about the series and how to submit here.
Alzheimer's Research & Therapy invites submissions for a thematic series focusing on the use of artificial intelligence, machine learning and related techniques in dementia research.
Find out more about the series and how to submit here.
In partnership with Research Square, Alzheimer's Research & Therapy is now offering In Review. Authors choosing this free optional service will be able to:
Read more about the full range of benefits of In Review and how to opt in, or see the In Review platform for yourself here.
Interested in an introduction to peer reviewing articles for Alzheimer's Research & Therapy?
Find out more about our ECR Peer Reviewer Panel!
Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.
Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.
20 September 2019
27 February 2019
Speed
56 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
128 days from submission to acceptance
25 days from acceptance to publication
Citation Impact
6.116 - 2-year Impact Factor
7.114 - 5-year Impact Factor
1.546 - Source Normalized Impact per Paper (SNIP)
2.298 - SCImago Journal Rank (SJR)
Usage
657,918 downloads
1,172 Altmetric mentions